Anti-PCSK9 Reference Antibody (alirocumab)
- Product Code: 140375
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used to lower low-density lipoprotein (LDL) cholesterol in patients with hypercholesterolemia, particularly in those with familial hypercholesterolemia or established cardiovascular disease. It is administered as a subcutaneous injection and works by inhibiting PCSK9, a protein that reduces the liver’s ability to remove LDL cholesterol from the blood. Often prescribed alongside statins or for patients who cannot tolerate statin therapy. Helps reduce the risk of major cardiovascular events such as heart attack and stroke in high-risk individuals.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 10-20 days | Ft52,285.42 |
+
-
|
Anti-PCSK9 Reference Antibody (alirocumab)
Used to lower low-density lipoprotein (LDL) cholesterol in patients with hypercholesterolemia, particularly in those with familial hypercholesterolemia or established cardiovascular disease. It is administered as a subcutaneous injection and works by inhibiting PCSK9, a protein that reduces the liver’s ability to remove LDL cholesterol from the blood. Often prescribed alongside statins or for patients who cannot tolerate statin therapy. Helps reduce the risk of major cardiovascular events such as heart attack and stroke in high-risk individuals.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :